0. Advocacy Graphic

ADVOCACY NEWS


  • March 14, 2019

    ASAM Writes to FDA Regarding Need for More Medication Treatment Options for Patients with SUD

    The dearth of FDA-approved pharmacotherapies for the treatment of substance use disorder (SUD) prompted ASAM to write to the Food and Drug Administration urging them to take into consideration the need for access to multiple treatment options for clinicians and their patients as they consider applications for new products to treat SUD.
  • February 25, 2019

    ASAM President Testifies Before Bipartisan Congressional Task Force on Opioid Overdose Epidemic

    Dr. Kelly J. Clark, president of ASAM, participated in a congressional roundtable sponsored by the House Bipartisan Heroin and Opioid Task Force. At the event, she urged lawmakers to make strategic investments in the substance use disorder (SUD) treatment workforce in order to close the addiction treatment gap and ensure the millions of Americans living with SUD are able to receive the care they need.
  • February 21, 2019

    ASAM Honors Recipients of 2019 Public Policy Award

    The American Society of Addiction Medicine (ASAM) is pleased to honor Representative Katherine Clark (D-MA-05) and Senator Rob Portman (R-OH) with the 2019 ASAM Public Policy Award.
  • February 12, 2019

    American College of Clinical Pharmacy Joins the Fight to Stop Opioid Overdose

    The Coalition to Stop Opioid Overdose is pleased to welcome the American College of Clinical Pharmacy (ACCP) to the coalition.
  • January 15, 2019

    The National Association for Behavioral Healthcare Joins the Fight to Stop Opioid Overdose

    The Coalition to Stop Opioid Overdose (CSOO) is thrilled to welcome the National Association for Behavioral Healthcare (NABH) as a new member of the coalition. NABH represents provider systems that are committed to the high-quality clinical care for people with mental health and substance use disorders.
  • January 10, 2019

    New Taxonomy Code

    Given the recognition of addiction medicine as a medical subspecialty by ABMS, with an established curriculum and training standards and a new certification pathway, ASAM believed it was timely and appropriate to request a new taxonomy code that would capture the distinctive nature of this area of specialty practice.
  • December 19, 2018

    ASAM Submits Comments to FDA Regarding Strategies to Increase Naloxone Availability

    ASAM submitted comments to the Food and Drug Administration (FDA) in response to a request for comment ahead of a public advisory committee meeting regarding strategies to increase the availability of naloxone products intended for use in the community.
  • December 18, 2018

    US Surgeon General Proclaims E-Cigarette Use an Epidemic Among Youth

    US Surgeon General Jerome M. Adams issued a rare public health Advisory declaring the use of e-cigarettes an “epidemic among our nation’s young people.” The Advisory provides information to parents, educators, and health professionals on new types of e-cigarettes on the market, including JUUL, and the negative health consequences of youth use of these products.